The acquisition will relaunch Rehab Boost as Medbridge Motion Capture, a key component of Medbridge AI, providing Medbridge with in-house motion capture and AI capabilities.
Researchers say significant geographic variations in concussion diagnoses in emergency departments highlight the need for strategies to address disparities.
The acquisition will relaunch Rehab Boost as Medbridge Motion Capture, a key component of Medbridge AI, providing Medbridge with in-house motion capture and AI capabilities.
Nervonik, a medical device startup, successfully completed its first-in-human clinical study for a novel peripheral nerve stimulation (PNS) device aimed at treating chronic pain, demonstrating safety, ...
Cerevance has initiated the Phase 3 ARISE trial to evaluate solengepras, a non-dopaminergic therapy targeting specific brain circuits, as a potential adjunctive treatment for Parkinson’s disease.